HK1135389A1 - Process for preparing n-alkyl naltrexone halides - Google Patents

Process for preparing n-alkyl naltrexone halides

Info

Publication number
HK1135389A1
HK1135389A1 HK10101845.3A HK10101845A HK1135389A1 HK 1135389 A1 HK1135389 A1 HK 1135389A1 HK 10101845 A HK10101845 A HK 10101845A HK 1135389 A1 HK1135389 A1 HK 1135389A1
Authority
HK
Hong Kong
Prior art keywords
halides
preparing
naltrexone
alkyl
alkyl naltrexone
Prior art date
Application number
HK10101845.3A
Other languages
English (en)
Inventor
Dlubala Alain
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HK1135389A1 publication Critical patent/HK1135389A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10101845.3A 2006-09-21 2010-02-22 Process for preparing n-alkyl naltrexone halides HK1135389A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0608286A FR2906252B1 (fr) 2006-09-21 2006-09-21 Procede de preparation d'halogenures de n-aklyl naltrexone
PCT/FR2007/001516 WO2008034973A1 (fr) 2006-09-21 2007-09-19 Procede de preparation d'halogenures de n-alkyl naltrexone

Publications (1)

Publication Number Publication Date
HK1135389A1 true HK1135389A1 (en) 2010-06-04

Family

ID=38016779

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101845.3A HK1135389A1 (en) 2006-09-21 2010-02-22 Process for preparing n-alkyl naltrexone halides

Country Status (36)

Country Link
US (2) US7645880B2 (me)
EP (1) EP2069362B1 (me)
JP (1) JP5214615B2 (me)
KR (1) KR101434693B1 (me)
CN (2) CN101516892B (me)
AR (1) AR062918A1 (me)
AU (1) AU2007298855B2 (me)
BR (1) BRPI0718440A2 (me)
CA (1) CA2663509C (me)
CL (1) CL2007002711A1 (me)
CO (1) CO6170362A2 (me)
CR (1) CR10660A (me)
DO (1) DOP2011000307A (me)
EA (1) EA015426B1 (me)
ES (1) ES2531093T3 (me)
FR (1) FR2906252B1 (me)
GT (1) GT200900060A (me)
HK (1) HK1135389A1 (me)
HN (1) HN2009000503A (me)
IL (1) IL197402A (me)
JO (1) JO3023B1 (me)
MA (1) MA30793B1 (me)
ME (1) ME00613B (me)
MX (1) MX2009003084A (me)
MY (1) MY148094A (me)
NI (1) NI200900035A (me)
NO (1) NO20091561L (me)
NZ (1) NZ575417A (me)
PE (1) PE20080867A1 (me)
SV (1) SV2009003192A (me)
TN (1) TN2009000080A1 (me)
TW (1) TWI465451B (me)
UA (1) UA96957C2 (me)
UY (1) UY30599A1 (me)
WO (1) WO2008034973A1 (me)
ZA (1) ZA200901846B (me)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008233133B2 (en) 2007-03-29 2014-03-27 Progenics Pharmaceuticals, Inc. Crystal forms of (R) -N-methylnaltrexone bromide and uses thereof
WO2008138383A1 (de) * 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
WO2009009292A2 (en) * 2007-07-11 2009-01-15 Mallinckrodt Inc. Crystalline forms of naltrexone methobromide
EP2019105A1 (en) * 2007-07-19 2009-01-28 Siegfried Ltd. Process for the preparation of quaternary n-alkyl morphine or morphinane alkaloid derivatives
CA2738246C (en) * 2008-09-30 2017-09-05 Mallinckrodt Inc. Processes for the alkylation of secondary amine groups of morphinan derivatives
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
CN102325776A (zh) * 2009-02-23 2012-01-18 马林克罗特公司 (+)-吗啡喃*季盐及其制备方法
JP2012518652A (ja) * 2009-02-23 2012-08-16 マリンクロッド インコーポレイテッド （＋）−６−ヒドロキシ−モルフィナンまたは（＋）−６−アミノ−モルフィナン誘導体
CN102325777B (zh) * 2009-02-23 2015-08-12 马林克罗特公司 (+)-吗啡喃*n-氧化物及其制备方法
KR20120088537A (ko) 2009-04-24 2012-08-08 브럭 유니버시티 모르피난 및 모르피논 화합물의 제조방법
US8829020B2 (en) 2009-07-16 2014-09-09 Mallinckrodt Llc Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
CN101845047B (zh) * 2009-12-31 2011-12-07 南京臣功制药有限公司 一种溴甲基纳曲酮的制备方法
US8580963B2 (en) 2010-11-05 2013-11-12 H. Lundbeck A/S Method for the manufacturing of naltrexone
JO3209B1 (ar) * 2010-11-05 2018-03-08 H Lundbeck As طريقة لتصنيع نالتريكسون
WO2012059103A1 (en) * 2010-11-05 2012-05-10 H. Lundbeck A/S Method for the manufacturing of naltrexone
WO2012138888A1 (en) 2011-04-05 2012-10-11 Alkermes, Inc. Process for the synthesis of quaternary amine compounds
BR112014005421A2 (pt) 2011-09-08 2017-04-04 Mallinckrodt Llc produção de alcaloides sem o isolamento de intermediários
CN103172640A (zh) * 2011-12-22 2013-06-26 天津康鸿医药科技发展有限公司 一种(r)-n-溴甲基纳曲酮的制备方法以及纳曲酮衍生物
AR090916A1 (es) 2012-05-03 2014-12-17 Lundbeck & Co As H Metodo para la fabricacion de naltrexona
CN105985348B (zh) * 2015-02-12 2019-02-01 正大天晴药业集团股份有限公司 一种溴甲基纳曲酮的制备方法
CN106317064B (zh) * 2015-06-30 2018-06-19 北大方正集团有限公司 溴甲纳曲酮的制备方法
KR102201609B1 (ko) * 2019-04-19 2021-01-12 연성정밀화학(주) 날데메딘의 제조방법
CN111777617A (zh) * 2020-07-10 2020-10-16 华润三九医药股份有限公司 一种溴甲纳曲酮的精制方法
EP4225312A1 (en) 2020-10-06 2023-08-16 Scilex Holding Company Oral delayed burst formulation of low-dose naltrexone or naloxone used for treating fibromyalgia and long covid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176186A (en) * 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
WO2004043964A2 (en) * 2002-11-08 2004-05-27 Mallinckrodt Inc. Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
AR057325A1 (es) * 2005-05-25 2007-11-28 Progenics Pharm Inc Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
GT200900060A (es) 2011-01-04
KR20090057031A (ko) 2009-06-03
WO2008034973A1 (fr) 2008-03-27
EA200970307A1 (ru) 2009-12-30
TWI465451B (zh) 2014-12-21
UA96957C2 (ru) 2011-12-26
CO6170362A2 (es) 2010-06-18
MY148094A (en) 2013-02-28
ZA200901846B (en) 2010-07-28
ES2531093T3 (es) 2015-03-10
CN101516892B (zh) 2012-06-20
CL2007002711A1 (es) 2008-04-18
UY30599A1 (es) 2008-05-02
FR2906252A1 (fr) 2008-03-28
CA2663509C (fr) 2014-03-18
EP2069362B1 (fr) 2014-07-09
AR062918A1 (es) 2008-12-17
BRPI0718440A2 (pt) 2013-11-19
KR101434693B1 (ko) 2014-08-27
CR10660A (es) 2009-06-24
MX2009003084A (es) 2009-04-02
NO20091561L (no) 2009-06-16
IL197402A (en) 2012-12-31
FR2906252B1 (fr) 2008-11-28
AU2007298855B2 (en) 2012-09-13
EP2069362A1 (fr) 2009-06-17
AU2007298855A1 (en) 2008-03-27
US20100145051A1 (en) 2010-06-10
US20080214817A1 (en) 2008-09-04
TW200821314A (en) 2008-05-16
PE20080867A1 (es) 2008-08-22
NZ575417A (en) 2011-09-30
IL197402A0 (en) 2009-12-24
JP5214615B2 (ja) 2013-06-19
EA015426B1 (ru) 2011-08-30
JP2010504308A (ja) 2010-02-12
CN102225939A (zh) 2011-10-26
CN101516892A (zh) 2009-08-26
NI200900035A (es) 2010-01-26
MA30793B1 (fr) 2009-10-01
US8288547B2 (en) 2012-10-16
TN2009000080A1 (en) 2010-08-19
MEP10509A (en) 2011-12-20
SV2009003192A (es) 2009-10-27
DOP2011000307A (es) 2011-10-31
ME00613B (me) 2011-12-20
US7645880B2 (en) 2010-01-12
JO3023B1 (ar) 2016-09-05
HN2009000503A (es) 2011-03-02
CA2663509A1 (fr) 2008-03-27

Similar Documents

Publication Publication Date Title
HK1135389A1 (en) Process for preparing n-alkyl naltrexone halides
AP2577A (en) Process for preparing diaminophenothiazinium compounds
HK1158628A1 (en) Process for preparing dihydropteridinone derivatives
EP2073636A4 (en) PROCESS FOR PREPARING OXYMORPHONE
IL198288A0 (en) Process for preparing difluoromethylpyrazolyl carboxylates
IL199124A (en) A process for preparing fluoromethyl-converted heterocyclic compounds
IL182067A0 (en) Process for preparing telmisartan
PL2213654T3 (pl) Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu
IL178001A0 (en) Process for preparing 5-methyl-2-furfural
PT2099738T (pt) Procedimento para produção de polieteraminas
PT2084128E (pt) Processo para a preparação de isocianatos
TWI372145B (en) Process for preparing alkylanilides
EP1751123A4 (en) PROCESS FOR PREPARING IRBESARTAN
HRP20150775T1 (en) Method for preparing hypoallergens
HK1111160A1 (en) Process for preparing
HK1112902A1 (en) Process for preparing protected amiidines
GB2456999B (en) Method for preparing 2-deoxy-L-ribose
IL196142A0 (en) Process for preparing amidrazones
ZA200806903B (en) Process for preparing dibenzothiazepine compounds
ZA200907695B (en) Process for preparing dorzolam ide
IL198686A0 (en) Process for preparing cinacalcet
IL195262A0 (en) Process for preparing hydroxylpatite
ZA200907810B (en) Process for preparing valsartan
EP2114883A4 (en) PROCESS FOR THE PREPARATION OF LERCANIDIPINE HYDROCHLORIDE
IL200389A0 (en) Process for preparing substituted phenylhydrazines

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170919